Eli Lilly, Boehringer Ingelheim gets USFDA nod for Jardiance to treat heart failure regardless of ejection fraction MD Bureau26 Feb 2022 11:00 AM ISTIndianapolis: Eli Lilly and Company and Boehringer Ingelheim have recently announced that the U.S. Food and Drug Administration (USFDA) has...
FDA approves Jardiance for heart failure in adults Dr. Kamal Kant Kohli25 Feb 2022 1:54 AM ISTThe U.S. Food and Drug Administration has approved diabetes drug Jardiance for heart failure in adults. This will help reduce the risk of...
Emperor preserved trial: Empagliflozin effective to treat heart failure Dr. Nandita Mohan10 Feb 2022 7:30 PM IST The EMPEROR-Preserved trial reports empagliflozin is superior to placebo in improving heart failure outcomes among patients with symptomatic...
SGLT2 inhibitor empagliflozin may improve brain's insulin sensitivity in prediabetics: Study Medha Baranwal28 Dec 2021 10:00 AM ISTGermany: Researchers in a recent study published in Diabetes Care have shown for the first time that the SGLT2 inhibitor empagliflozin can be used for...
Empagliflozin retains benefits in 'True' HFpEF Patients Ruchika Sharma3 Dec 2021 5:31 PM ISTEmpagliflozin provides a wide range of benefits in patients with "true" heart failure and preserved ejection fraction (HFpEF) , meaning an LVEF of 50%...
Empagliflozin safe in acute HF, improves 'Clinical Benefit' over time Dr. Nandita Mohan2 Dec 2021 10:42 AM ISTPatients with acute heart failure were safely started on empagliflozin a median of 3 days after hospitalization and were 36% more likely to...
Empagliflozin increases QoL and overall survival in adults with acute heart failure: AHA MD Editorial Team15 Nov 2021 7:46 PM ISTAccording to late-breaking research presented at the American Heart Association's Scientific Sessions 2021 on 14th November 2021, adults treated with...
Ursolic acid and empagliflozin combo better for treating diabetic nephropathy, study finds Medha Baranwal11 Nov 2021 9:00 AM ISTChina: A recent study in the journal Biomedicine & Pharmacotherapy has shown that a combination of ursolic acid (UA) and empagliflozin (EM) is...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Roshni Dhar1 Nov 2021 11:24 AM ISTIn a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 29/October/2021 Roshni Dhar30 Oct 2021 11:09 AM ISTHere are Top Health Stories of the dayMadras HC slams Medical Council for removing gastroenterologist's name, gives 14 pointer guidelinesSlamming the...
RYGB reduces microalbuminuria and A1c better than empagliflozin and liraglutide: Study Dr. Shravani Dali28 Oct 2021 10:00 AM ISTIndividuals who receive Roux-en-Y Gastric Bypass have a greater reduction in microalbuminuria and A1c compared with those treated with empagliflozin...
Boehringer Ingelheim gets CDSCO panel nod to market Jardiance for additional indication Medical Dialogues Team27 Oct 2021 1:21 PM ISTNew Delhi: In a significant development, drug-major Boehringer has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
